Aurobindo Pharma USA will acquire Lannett from Lannett Seller Holdco for $250 million on a cash-free, debt-free basis.

Aurobindo Pharma to acquire US-based Lannett for $250M, gaining a strategic local manufacturing base to offset tariffs and ...

Aurobindo Pharma USA acquires Lannett Company LLC for $250 million, expanding U.S. manufacturing capabilities and product ...

The transaction is valued at an enterprise value of $250 million (₹21,850 crore) on a cash-free, debt-free basis, including ...

Hyderabad: Amid rising fears of US President Donald Trump imposing tariffs on Indian pharma imports, Aurobindo Pharma is ...

The deal is being carried out on a cash-free, debt-free basis, factoring in standardised working capital levels.

Hyderabad: In a major strategic move, Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Aurobindo ...

Indian drugmakers are responding with geographic diversification, supply-chain resilience and acquisition of US assets to ...

Stocks like Tata Steel, Aurobindo Pharma, Gujarat Gas, Navin Fluorine International, Hitachi Energy, Sagility India, ...

Stocks to Watch Today, Thursday, July 31, 2025: Indian equity markets are expected to start on a lower note on Thursday ...

The domestic markets are likely to open on a lower note as the US has imposed a 25% tariff on Indian goods, rattling investor ...